*This* Is Why Cops Should Open Fire on Drivers Who Try to Run...
Guess Who Iran's Supreme Leader Blames for Nationwide Unrest
Taking Action on Walz’s Minnesota Fraud Scandal
Nebraska Democrat Tears Down Patriotic Exhibit As America Prepares for 250th Birthday
The U.S. Has Seized Another Tanker of Embargoed Venezuelan Oil
Target Hasn't Completely Dumped the Woke Nonsense
Oregon Democrats Defend Violent Venezuelan Gang Member After Another ICE-Involved Shooting...
Venezuelans Are Trolling Maduro in Prison, and It's Glorious
'Seeking Peace:' President Trump Reports Venezuela Is Releasing 'Large Number' of Politica...
Wisconsin Man Pleads Guilty After Killing Parents to Finance Trump Assassination Plan
In Mamdani's New York, Cheering for Hamas Is Now the Norm
Kamikaze Leftists: Desperation in the Age of DOGE
Mamdani and Allies Rally Behind Controversial Tenant Director Pick After Racist Posts Resu...
Woman Shot by ICE Agent Identified As Member of Radical 'ICE Watch' Group...
The December Jobs Report Is Here
Tipsheet

Trump Takes Aim at Gain-of-Function Research in Latest Executive Order

AP Photo/Evan Vucci

President Trump signed an executive order on Monday ending current and future federal funding for gain-of-function research in certain countries, such as China and Iran.

Advertisement

The order seeks to protect Americans from this type of “dangerous” research and any lab accidents and biosecurity incidents that most likely caused the COVID-19 pandemic.

American innovation will not be impeded by the order, according to the White House, but it will increase the safety and security of biological research in the U.S.

  • For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
  • The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
  • The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (“DURC/PEPP”) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
  • This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
  • Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight. (White House)
Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement